Teva And Celltrion Gain Arthritis Advantage On Rituximab
Truxima Biosimilar Now Available In Rheumatoid Arthritis Indication In US
• By Akriti Seth and David Wallace
Teva is aiming to take advantage of its exclusive indication for its rituximab biosimilar • Source: Shutterstock 
